Ricky Zipp

3 weeks ago | medtechdive.com | Ricky Zipp

Editor’s note: This is the second story in a two-part series about the medtech industry’s IPO environment. You can read the first story on whether the medtech IPO window is finally open here.  The medical device industry was in a three-year drought for initial public offerings before a handful of companies went public in a short span, possibly opening the sector’s IPO window for the first time since a 2021 spike.

1 month ago | medtechdive.com | Ricky Zipp

This audio is auto-generated. Please let us know if you have feedback. Editor's note: This is the first story in a two-part series on the medtech IPO landscape. You can read the second story on how to take a company public here. When Ceribell went public in October, the window for medtech initial public offerings was open just a crack — if not shut completely.

1 month ago | medtechdive.com | Ricky Zipp

This audio is auto-generated. Please let us know if you have feedback. By the numbersFY 2025 revenue: $33.5 billion3.6% growth year over yearDiabetes revenue: $2.76 billion10.7% growth year over yearMedtronic said Wednesday that it plans to spin off its diabetes business in the next 18 months, creating a new diabetes technology company that can offer customers both insulin pumps and continuous glucose monitors.

1 month ago | manufacturingdive.com | David Kiley |Sara Samora |Nathan Owens |Ricky Zipp

From tractor manufacturing to drugs and chemicals, companies across the industry are feeling the brunt of the Trump administration’s heavy tariff policies. During first quarter earnings season, executives detailed their plans to soften the blow of tariffs, which are costing manufacturers hundreds of millions of dollars in lost revenue and heightened input costs. Ford Motor Co. is facing some of the worst impacts — the company expects up to $1.5 billion in lost net profits.

1 month ago | medtechdive.com | Ricky Zipp

This audio is auto-generated. Please let us know if you have feedback. Cardinal Health executives said Thursday that the company has laid off employees to help offset hundreds of millions of dollars in charges due to President Donald Trump’s tariff policies. The company forecast a range of $200 million to $300 million in costs due to tariffs in its fiscal year 2026, which historically has begun in July.